CD180 and systemic sclerosis: Of note, anti-CD180 stimulation induced natural autoantibody production and significantly increased the concentration of IL-6 in the supernatant of healthy tonsillar B cells providing a mechanism by which CD180 stimulation could increase the number of CD180-negative autoantibody producing B cells in SSc (83).